CMV-induced neonatal thrombocytopenia: a case report and review of the literature

NCBI PubMed A service of the U.S. National Library of Medicine
and the National Institutes of Health My NCBI



1: Am J Perinatol. 2007 Aug;24(7):429-34. Epub 2007 Jun 27.Related Articles, Links
CMV-induced neonatal thrombocytopenia: a case report and review of the literature.

Aslam M, Anderson JL, Guglietti D, Cardwell D.

Harvard Neonatal-Perinatal Fellowship Program, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

Cytomegalovirus (CMV) is a member of the Herpesviridae family of DNA viruses. It is unique in its ability to cause latent infection with secondary reactivation. Neonatal infection results from congenital and/or perinatal transmission. We present the case of a full-term infant with petechiae and splenomegaly at birth with no significant antenatal history. She was noted to have thrombocytopenia, but maternal platelet count was normal. Routine workup was normal, which prompted evaluation for toxoplasmosis, other infections, rubella, cytomegalovirus, and herpes simplex (TORCH infection); she was noted to have a positive urine CMV. She received multiple platelet transfusions and after consultation with an infectious disease specialist, she was started on intravenous (IV) ganciclovir. She continued to have persistent thrombocytopenia and received three doses of CMV immunoglobulin with gradual resolution. IV ganciclovir was changed to oral valganciclovir for a total treatment duration of 6 weeks. She failed her hearing screen, but eye examination was normal. She was discharged home after clinical stabilization with a close follow-up.

Publication Types:
Case Reports
Review

PMID: 17597443 [PubMed - indexed for MEDLINE]

NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer